Orally Dissolvable CBD Tablets with Mushroom Mycelia Bitter Blockers
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing CBD delivery systems fail to adequately mask the bitter taste of cannabidiol (CBD) for products with longer oral resident times, especially at higher dosages, and rely on excessive sugars or flavors which are undesirable for health-conscious consumers.
Innovation Solution
A solid composition combining encapsulated CBD, Cordyceps sinensis mycelia as a bitter blocker, and minimal sweeteners like stevia, spray dried onto a substrate like maltodextrin, to create an orally dissolvable tablet that masks bitterness effectively without added sugars.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If CBD is delivered in higher dosages with longer oral resident times, then therapeutic effects are improved, but bitter taste detection increases
Solution Approach 1:
Mushroom mycelia act as an intermediary substance that physically interacts with CBD on the tongue, blocking bitter taste receptors. The mycelia serve as a mediator between CBD and taste receptors, preventing the bitter taste from being detected while allowing CBD to remain in the oral cavity for extended therapeutic effect.
Solution Approach 2:
The patent changes the physical and chemical parameters of CBD by encapsulating it in maltodextrin and combining it with mushroom mycelia. This alters the taste profile and release characteristics of CBD, enabling higher dosages to be delivered without proportionally increasing bitter taste detection.
2Object-affected harmful factors
If excessive sugars or flavors are added to mask bitter taste, then bitter taste detection is reduced, but health concerns increase
Solution Approach 1:
Mushroom mycelia serve as a natural, health-conscious alternative to sugars and artificial flavors for masking bitter taste. The mycelia physically block taste receptors without introducing the health concerns associated with excessive sugar or flavor additive consumption.
Solution Approach 2:
The mushroom mycelia act as a temporary, single-use masking agent that is consumed along with the CBD product. This disposable approach to taste masking avoids the need for persistent sweeteners or flavors that would require ongoing health monitoring.
3Object-affected harmful factors
If CBD is encapsulated and spray dried onto substrate, then bitter taste is masked and oral dissolution is enabled, but manufacturing complexity increases
Solution Approach 1:
The patent utilizes spray drying, which involves phase transition from liquid emulsion to solid powder form. This process encapsulates CBD in maltodextrin and creates an orally dissolvable solid composition that masks bitter taste while enabling standardized manufacturing through controlled phase change.
Solution Approach 2:
The invention creates a composite material system combining CBD, maltodextrin encapsulant, and mushroom mycelia. This composite approach integrates multiple functional components into a single manufacturable product that simultaneously achieves taste masking, oral dissolution, and therapeutic delivery.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The combination allows for prolonged delivery of CBD through the oral mucosa, bypassing first-pass metabolism, with rapid therapeutic effects and minimal bitter taste detection, suitable for higher dosages without the need for excessive sweeteners or mycelia.
Implementation Method 1
spray drying the emulsion onto a substrate to obtain a powder
Data Source
AI summary
The present invention discloses orally dissolvable solid CBD compositions comprising encapsulated CBD, mushroom mycelia, and flavor.